Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the clinical efficacy of Xuefu Zhuyu Decoction in the treatment of unstable angina pectoris. All of the patients will be divided into 2 arms randomly. One of the arms will be treated by conventional western medicine, the other one will be treated by Xuefu Zhuyu Decoction at the base of conventional western medicine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.

NCT03179527

Unstable Angina

UNKNOWN PHASE4

Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.

NCT03171597

Unstable Angina

UNKNOWN PHASE4

Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.

NCT03179514

Unstable Angina

UNKNOWN PHASE4

Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine

NCT04022031

Atherosclerotic Heart Disease With Angina Nos

UNKNOWN

Retrospective Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine

NCT04026724

Atherosclerotic Heart Disease With Angina Nos

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Xuefu Zhuyu Decoction has the function of activating qi and promoting blood circulation, which will be used to treat patients with qi stagnation and blood stasis syndrome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unstable Angina

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Qi stagnation and blood stasis

Patients in this group will be treated by Xuefu Zhuyu Decoction at the base of conventional western medicine.

Group Type EXPERIMENTAL

Anti-Platelet Drugs

Intervention Type DRUG

Including aspirin and clopidogrel, etc.

Lipid Regulating Drugs

Intervention Type DRUG

Mainly including statins

Coronary Vasodilator

Intervention Type DRUG

Mainly including nitrates

Xuefu Zhuyu Decoction

Intervention Type DRUG

Mainly including Peach Kernel, Safflower, Angelica, Bupleurum etc.

Conventional western medicine

Patients in this group will be treated by conventional western medicine, including anti-platelet drugss，lipid regulating drugs, coronary vasodilator, etc.

Group Type OTHER

Anti-Platelet Drugs

Intervention Type DRUG

Including aspirin and clopidogrel, etc.

Lipid Regulating Drugs

Intervention Type DRUG

Mainly including statins

Coronary Vasodilator

Intervention Type DRUG

Mainly including nitrates

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anti-Platelet Drugs

Including aspirin and clopidogrel, etc.

Intervention Type DRUG

Lipid Regulating Drugs

Mainly including statins

Intervention Type DRUG

Coronary Vasodilator

Mainly including nitrates

Intervention Type DRUG

Xuefu Zhuyu Decoction

Mainly including Peach Kernel, Safflower, Angelica, Bupleurum etc.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants diagnosed with coronary heart disease through coronary angiography or coronary CTA;

Patients have at least one of these symptoms:

1. The stability of the nature of angina pectoris changes, that is, frequent attacks of angina pectoris, serious degree and prolonged duration;
2. Angina pectoris during rest;
3. The recent occurrence of angina pectoris caused by mild physical activity in the last month.

Exclusion Criteria

* Patients diagnosed with stable angina; Patients with acute myocardial infarction; Chest pain caused by congenital heart disease, valvular heart disease, severe neurosis or arrhythmia; The heart function grade is III or IV; Patients with acute cerebral infarction; Patients complicated with other serious primary diseases; Patients with acute infection in recent 2 weeks; Uncontrolled hypertension (the resting blood pressure \>160/95mmHg within one week); Diabetics emerged with serious diabetic complications; Patients can't finish the questionnaire due to abnormal mental and nervous or mental disorders; Pregnant or lactating women.

Minimum Eligible Age

35 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No